2m 2m 2m 2m 2m 2m 2m
INDIVIOR PHARMA (INDV)
NASDAQ
$36.84-$0.03 (-0.09%)
Price as of Aug 21, 2026 7:59 PM EDT- $4.4BMarket Cap
- 51.60%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INDIVIOR PHARMA (INDV)
$36.84-$0.03 (-0.09%)
INDV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $36.87 | ||
Change | -$0.91 (-2.41%) | ||
Open | $37.68 | ||
High | $38.52 | ||
Low | $36.70 | ||
Previous Close | $37.78 | ||
Volume | 2,496,842 | ||
30-Day Average Volume | 2,383,484 | ||
1-Week Change | -5.49% | ||
1-Month Change | -8.85% | ||
1-Year Change | 51.60% | ||
3-Year Change | 56.96% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 118.0M | ||
Total Assets | $1.2B | ||
Market Cap | $4.4B | ||
Enterprise Value | $4.6B | ||
Period: QTR TTM FY | |||
Revenue | $343.0M | ||
Net Income | $122.0M | ||
Free Cash Flow | $222.0M | ||
EBIT | $160.0M | ||
EBITDA | $162.0M | ||
Net Working Capital | -$143.0M | ||
EPS | $0.98 | ||
Enterprise Value/EBITDA | 28 | ||
Enterprise Value/Revenue | 13 | ||
P/B | -21 | ||
P/E | 38 | ||
PEG | 1 | ||
Price/Free Cash Flow | 20 | ||
Price/Operating Cash Flow | 19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue